Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…
Construction begins for the Berlin Center for Gene and Cell Therapies
Berlin, September 16, 2025 – A groundbreaking ceremony kicked off the construction work for the Berlin Center for…